The MarketWatch News Department was not involved in the creation of this content.-- Application submitted for manufacturing and marketing approval of ripretinib in Japan for the i ...
The "Animal Protein Ingredients Market – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report has been ...
Every month, we share opportunities for artists and designers, including open calls, grants, fellowships, and residencies.
EMA validates Eisai & Nuvation Bio’s MAA for taletrectinib for the treatment of advanced ROS1-positive NSCLC: Tokyo Monday, March 30, 2026, 11:00 Hrs [IST] Eisai Co., Ltd., a hu ...
Planned expansion supports the TPSCo announced transition while strengthening Tower’s differentiated optical and photonics ...
Researchers in Japan have reported a significant step in the long‑standing scientific effort to develop an insulin medication ...
Ono Pharma seeks Japanese manufacturing and marketing approval for ripretinib to treat advanced gastrointestinal stromal tumour: Osaka, Japan Friday, March 27, 2026, 17:00 Hrs [IS ...
White House AI power pledge drives shift toward microgrids; GenerMotor’s single‑conversion native DC offers AI server ...
BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases ...
Closes Private Placement Financing of Up to $104.5 Million – Secures Orphan Drug Designations for QRX003 for Netherton ...
The food & beverage industry outlook covers key areas such as plant-based proteins, functional food ingredients, pathogen testing, food certification, precision fermentation, food robotics, 3D ...
Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results